Adrenocortical carcinoma: Impact of surgical treatment.
Adrenocortical carcinoma: Impact of surgical treatment.
Ann Endocrinol (Paris). 2019 Oct 18;:
Authors: Mirallié E, Blanchard C, Caillard C, Rodien P, Briet C, Mucci S, Drui D, Hamy A
Abstract
Compared to benign adrenal lesions, secreting or otherwise, malignant adrenocortical carcinoma is rare. Overall prognosis is poor, with <50% 5-year survival. Various prognostic factors have been identified, some tumor-related and others directly linked to surgical treatment. Surgery is the only possible curative treatment, and is decided upon in a multidisciplinary medical-surgical team meeting. Surgical approach (laparotomy vs. laparoscopy) remains a matter of debate. In the light of a recent literature search, the present review reassesses the prognostic criteria of surgical resection, the quality of which determines overall and recurrence-free survival.
PMID: 31722787 [PubMed - as supplied by publisher]
Source: Annales d'Endocrinologie - Category: Endocrinology Authors: Mirallié E, Blanchard C, Caillard C, Rodien P, Briet C, Mucci S, Drui D, Hamy A Tags: Ann Endocrinol (Paris) Source Type: research
More News: Adrenocortical Carcinoma | Cancer & Oncology | Carcinoma | Endocrinology | Laparoscopy | Laparotomy